Ben is a patent litigator with nearly 30 years of experience enforcing
patent rights in the life sciences industry who focuses on Hatch
Waxman Abbreviated New Drug Application (ANDA) litigation. An
accomplished trial lawyer, Ben has tried numerous high-profile
cases on behalf of major pharmaceutical and technology companies.
He was a U.S. patent examiner from 1986 to 1990.
Ben is well versed in U.S. Patent and Trademark Office proceedings
and assists clients in post-grant and contested patent office
proceedings. He also conducts intellectual property due diligence
investigations in connection with acquisitions and licensing deals.
Ben is deeply involved in his clients’ matters, ensuring that he
understands all aspects of their businesses and cases so that he can
identify, dissect and solve potential challenges facing his clients.
According to Chambers USA 2014, Ben is a “favorite of high-profile
branded drug companies.” Chambers USA 2018 describes Ben as “a
very detail-oriented attorney.” He is an active member of the legal
community and frequently speaks on topics involving intellectual
property and litigation.
Ben is fluent in Mandarin Chinese.